View Older Stories View More Recent Stories
-
Applied Optoelectronics (AAOI) Prices 3M Common Follow-On at $24.25/Share
-
Applied Optoelectronics Announces Pricing of Follow-on Public Offering
-
Roth Capital Starts Concert Pharmaceuticals (CNCE) at Buy
-
Roth Lifts PT on SolarCity (SCTY) to $80; Notes GAAP Measures are Often Underestimated
-
Roth Still Bullish on Ligand Pharma (LGND) Following NOXAFIL Approval (MRK)
-
Roth Cuts PT on Galena Biopharma (GALE) on SEC Risk
-
Roth Reaffirms Peregrine Pharma (PPHM) at Buy; Prelim. Bavituximab + Sorafenib Phase I/II is Positive
-
Roth Keeps ImmunoCellular (IMUC) at Neutral; Sidelined Until ICT-107 Picture Clears
-
Notable Analyst Rating Changes 03/14: (TEVA) (SIRI) (LOW) Upgraded; (PLUG) (XOXO) (NUE) Downgraded
-
Roth Keeps Keryx Biopharma (KERX) at Buy; Zerenex Potential Remains Strong
-
Pre-Open Stock Movers 3/14: (HART) (MEET) (LMCA) Higher; (ARO) (ZBB) (PLUG) Lower (more...)
-
Roth Capital Downgrades Plug Power (PLUG) to Neutral
-
GenVec (GNVC) to Place $9M of Common at $3.15/Share
-
TG Therapeutics, Inc. Announces $18.1 Million Underwritten Sale of Common Stock to a Single Institutional Investor
-
OXiGENE Announces Updated Time for Presentation at the ROTH Conference
-
Roth Boosts PT on Hydrogenics (HYGS) to $40; P2G Will Eventually Provide Long-Term Growth
-
Key Takeaways From ROTH 2014 OC Conference (SCTY) (CSIQ) (JASO)
-
Odyssey Marine Exploration Reports Record Fourth Quarter and Full Year 2013 Results
-
Can-Fite BioPharma (CANF) Closes 1.48M ADS, Warrants Private Placement
-
Roth Starts JA Solar (JASO) at Buy; Undervalued Name has Robust Balance Sheet, Strong Pipeline
-
Electrovaya to Present at the Roth Capital Conference on March 12, 2014
-
BioLineRx (BLRX) Closes 9.66M ADS Offering for Gross Proceeds of $24.1M
-
Peregrine (PPHM) Risk/Reward Still Favorable; Plenty to Look Forward to in FY14 - Roth
-
Notable Analyst Rating Changes 03/07: (GTAT) (CCRN) (PRU) Upgraded; (ALU) (NMRX) (VMEM) Downgraded
-
Roth Capital Starts JA Solar Holdings Co., Ltd. (JASO) at Buy
-
Roth Capital Starts Applied Micro Circuits (AMCC) at Buy
-
OXiGENE Announces Presentation at the ROTH Conference on March 11, 2014
-
Roth Keeps Spectrum Pharma (SPPI) at Buy; Q4 Results are Speed Bump on Road to Profitability
-
AETI CEO to Present at ROTH Capital Partners 26th Annual Growth Stock Conference
-
Roth Capital Starts Conatus Pharmaceuticals (CNAT) at Buy
-
Roth Capital Downgrades Kindred Biosciences (KIN) to Neutral
-
Applied Optoelectronics (AAOI) Announces 1.3M Common Follow-On Offering
-
Applied Optoelectronics Files Registration Statement for Proposed Follow-on Public Offering
-
Roth Keeps Verastem (VSTM) at Buy; Sees Positioned for 'Potentially Transformative Year'
-
Pixelworks (PXLW) PT Raised to $10 at Roth
-
Notable Analyst Rating Changes 03/06: (BIIB) (COG) (HA) Upgraded; (AUXL) (LOV) (ARTC) Downgraded
-
Buy Canadian Solar (CSIQ) on Weakness; FY14 Outlook Reinforces Strength - Roth
-
GSV Capital Corp. to Present at the 26th Annual ROTH Conference on March 10, 2014
-
Roth Capital Starts Durata Therapeutics (DRTX) at Buy
-
Vical to Present at the ROTH Capital Partners 26th Annual Growth Stock Conference
-
Notable Analyst Rating Changes 03/05: (P) (TRMB) (DST) Upgraded; (DDS) (SPLS) (PEI) Downgraded
-
Pre-Open Stock Movers 3/5: (FCEL) (ARWR) (SWHC) Higher; (XOMA) (HCI) (CSIQ) Lower (more...)
-
ANI Pharma (ANIP) Prices 1.4M Common Stock Offering at $31/Share
-
Arno Therapeutics to Present at 26th Annual ROTH Conference
-
Roth Restarts Cytokinetics (CYTK) at Buy; Get in Now Ahead of April '14 ALS Data
-
Roth Capital Re-Initiated Cytokinetics (CYTK) at Buy
-
After Hours Stock Movers 3/4: (BV) (SWHC) (AVAV) Higher; (XOMA) (CHEF) (THOR) Lower (more...)
-
ANI Pharma (ANIP) Plans Common Stock Offering
-
Reis, Inc. to Present to Investors at Roth Capital Partners 26th Annual Conference
-
JinkoSolar (JKS) Issues Confident Q4 Beat, FY14 Outlook is Strong; Roth Keeps at 'Buy'

